United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 21, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...